SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-067500
Filing Date
2014-11-10
Accepted
2014-11-10 11:14:53
Documents
1
Period of Report
2014-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2935
  Complete submission text file 0001209191-14-067500.txt   4803
Mailing Address 5-1, NIHONBASHI 3-CHOME CHUO-KU, TOKYO M0 103-8426
Business Address 5-1, NIHONBASHI 3-CHOME CHUO-KU, TOKYO M0 103-8426 (011) 81-3-5255-7041
Daiichi Sankyo Company, LTD (Reporting) CIK: 0001340156 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-36721 | Film No.: 141207289
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DENNIS M. LANFEAR 201 REDWOOD SHORES PARKWAY, SUITE 200 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 201 REDWOOD SHORES PARKWAY, SUITE 200 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Issuer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)